(Date:7/2/2008)... develops new therapies based on cells manufacture.../S provide funding round, SALT LAKE CITY and HAMB..., a biotechnology company at the forefront of inno...idney injury, today announced the closing of a,$14...ife Sciences with Novo,A/S joining the syndicate.,...
(Date:7/2/2008).../- Aureus Pharma, a leading provider ...scovery in the life science,industry, announced to...l,be held in Paris on October 23rd and 24th., Thi...inaugural event,which was attended by many of Aure... Europe and North America. The symposium included ...
(Date:7/2/2008)...ance Commercialization of Expanded Portfolio of Va...ANCOUVER, British Columbia, July 2 /-...es Corp. (TSXV: MEV), a company developing and,mar...y announced its name,change and the expansion of i... acquisition of two vascular product development c...
(Date:7/2/2008)...ts to potential of pre-treatment R2 levels as a po...tivity -, TORONTO, July 2 /PRNewswire-FirstCall/ ...Lorus" or the "Corporation"), a biopharmaceutical ...nt of pharmaceutical products and,technologies for...tion by,an Ohio State University (OSU) clinical te...
Breaking Biology Technology:AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury 2AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury 3Aureus Pharma Announces Date of 2008 Annual User Symposium 2Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 2Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 3Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 4Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 2Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 3Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 4Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 5...es of oil and natural gas have sparked a race to m... of petroleum, and both biodiesel and gasoline con...the market. , ,But the oil price hike has also fu...mediates - compounds that are the raw material for...e scenes, American industry uses millions of tons ...
...ting a lengthy financial investigation in response... has announced the resignations of three executive...y of material errors in its financial statements. ...company officials came true as the value of Merge ...nouncement. , ,Following a meeting of the company,...
...ines, you might conclude Wisconsin,s economy is he...uts hit home: GM, Delphi workers take buyouts" ,"A...health deal" ,"Walworth County loses bid as Honda ...these news stories, you might just as easily think...sperity. , ,"Nursing home supplier to expand in Mi...
...month-old citywide wireless Internet system has so...hing coffee shop regulars. , , Mad City Broadband ...Inc., manages Madison,s Wi-Fi system, which was la...in February and became a subscription-based servic...ther consumers, already served by existing wireles...
Other Biology Technology:UW prof turns sugar into diesel fuel, chemicals 2UW prof turns sugar into diesel fuel, chemicals 3Merge execs step down following investigation 2Merge execs step down following investigation 3Is Wisconsin's economy stronger, weaker, or just changing? 2Is Wisconsin's economy stronger, weaker, or just changing? 3Some Madisonians content without city wireless 2Some Madisonians content without city wireless 3Some Madisonians content without city wireless 4Some Madisonians content without city wireless 5(Date:7/3/2008)...stors of such marine creatures as clams, sand doll...ng 144 million years ago with no clear trend after...rchers. This contradicts previous work showing dra...d may shed light on future diversity., "Some of ...t is happening today from global warming," says Jo...
(Date:7/3/2008)..., 2008 -- Sirtris, a GlaxoSmithKline company focus...ugs to treat diseases of aging such as Type 2 Diab...ted in today,s online edition of Cell Metabolism ...e with resveratrol showed an overall health improv... in cataracts and cardiovascular dysfunction, and ...
(Date:7/3/2008)...hris Smit has concluded that small mammals, such a...opment of natural diversity. Smit researched how s...seems that prickly shrubs are important in protect...ing. Smit has also demonstrated that natural distu...ery important for the diversity of natural areas. ...
(Date:7/2/2008)...h team has published the first clear example of ho...diseases that are normally tolerated singly may co... , In a report issued June 25 by PLoS ONE, an ... examined outbreaks of canine distemper virus (CDV... mortality in Serengeti lions. CDV cycles periodic...
Breaking Biology News(10 mins):Ancient marine invertebrate diversity less explosive than thought 2Ancient marine invertebrate diversity less explosive than thought 3Long-term study of middle-aged mice shows 2Long-term study of middle-aged mice shows 3Tasty meal out of reach 2Big Opportunities Are in the Bag for Food Retailers 13548 1Big Opportunities Are in the Bag for Food Retailers 13548 2ExonHit Therapeutics 2007 Financial Results 3736 1ExonHit Therapeutics 2007 Financial Results 3736 2ExonHit Therapeutics 2007 Financial Results 3736 3ExonHit Therapeutics 2007 Financial Results 3736 4ExonHit Therapeutics 2007 Financial Results 3736 5ExonHit Therapeutics 2007 Financial Results 3736 6ExonHit Therapeutics 2007 Financial Results 3736 7ExonHit Therapeutics 2007 Financial Results 3736 8ExonHit Therapeutics 2007 Financial Results 3736 9ExonHit Therapeutics 2007 Financial Results 3736 10ExonHit Therapeutics 2007 Financial Results 3736 11ExonHit Therapeutics 2007 Financial Results 3736 12Type 2 diabetes may be caused by intestinal dysfunction 13542 1Type 2 diabetes may be caused by intestinal dysfunction 13542 2Type 2 diabetes may be caused by intestinal dysfunction 13542 3Type 2 diabetes may be caused by intestinal dysfunction 13542 4Protein in Human Embryonic Stem Cells Controls Malignant Tumor Cells 13538 1Protein in Human Embryonic Stem Cells Controls Malignant Tumor Cells 13538 2Protein in Human Embryonic Stem Cells Controls Malignant Tumor Cells 13538 3Protein in Human Embryonic Stem Cells Controls Malignant Tumor Cells 13538 4...t time, you can identify and characterize high-val...tly without interferences. The Agilent Multiple Af...d, multiple high-abundant proteins from human seru...ice. With this revolutionary system, you can: Re...
...olor RNA Spike-In Kit contains in vitro synthesize...neal only to complementary control probes on Agile...dization. The spike-ins serve as a positive microa...TE: This kit is a required component of the Agilen...
...e one mouse-click image analysis software for micr...is the solution for high quality and high throughp...ith VigeneTechs robust algorithms, actual spot bou...ckground correction and dust removal, enhancing th...
...eomic Imaging System, Professional Package Superi...Dynamic Range: The ProXPRESS 2D Proteomic Imaging ... both proteomic and general life science research ...lexibility, enabling the use of all dyes in the UV...
Biology Products: